1 min read
Add as a preferred source on GoogleTELA Bio Implements Initiative to Cut Annual Operating Expenses by $17 Million
The company had substantially completed the reductions by the end of the third quarter of 2026.
TELA Bio implemented an initiative to reduce annual operating expenses by $17 million, with the cuts substantially complete by the end of the third quarter of 2026.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.